Activation of Nrf2/HO-1 by Peptide YD1 Attenuates Inflammatory Symptoms through Suppression of TLR4/MYyD88/NF-κB Signaling Cascade

In this study, we investigate the immunomodulatory effects of a novel antimicrobial peptide, YD1, isolated from Kimchi, in both in vitro and in vivo models. We establish that YD1 exerts its anti-inflammatory effects via up-regulation of the Nrf2 pathway, resulting in the production of HO-1, which suppresses activation of the NF-kappa B pathway, including the subsequent proinflammatory cytokines IL-1 beta, IL-6, and TNF-alpha. We also found that YD1 robustly suppresses nitric oxide (NO) and prostaglandin E2 (PGE(2)) production by down-regulating the expression of the upstream genes, iNOS and COX-2, acting as a strong antioxidant. Collectively, YD1 exhibits vigorous anti-inflammatory and antioxidant activity, presenting it as an interesting potential therapeutic agent.

Automated summary

The novel antimicrobial peptide YD1 isolated from Kimchi exhibits strong anti-inflammatory effects by up-regulating the Nrf2 pathway and suppressing the NF-kappa B pathway, resulting in reduced proinflammatory cytokine production. YD1 also acts as a potent antioxidant by inhibiting NO and PGE(2) production, indicating its potential as a therapeutic agent.